This is a key intracellular signaling system that drives cellular growth and survival, and emerging evidence indicates that hyperactivation of the PI3K/AKT/mTOR pathway is a key mechanism of endocrine resistance in HR+ breast cancer.12 Here, MTOR is linked to breast carcinoma.